BPC-157 + TB-500 Stack Dosing Protocol
The BPC-157 and TB-500 combination is the most popular healing peptide stack. BPC-157 provides targeted local tissue repair while TB-500 offers systemic wound healing support through complementary mechanisms.
Key Points
Step-by-Step Guide
BPC-157 Component
Administer 250-500 mcg subcutaneously near the target area, 1-2x daily. For systemic applications, rotate between abdominal fat pad and nearest site to the affected area.
TB-500 Component
Loading: 2-2.5 mg twice weekly for 4-6 weeks. Maintenance: 2 mg once weekly. Inject subcutaneously at any convenient site.
Timing
Both can be injected at the same time of day but use separate injection sites. Consistency in timing matters more than specific time.
Duration
Run 6-8 weeks minimum. TB-500 loading phase determines minimum duration. After completion, take 4 weeks off before potential restart.
Track Progress
Document pain levels, range of motion, and functional capacity daily. Take progress photos. Expect noticeable improvement within 2-3 weeks.
Separate Injections
Keep peptides in separate vials. Draw each separately. Do not pre-mix in the same vial to avoid stability issues between the two compounds.
Warnings & Precautions
- !No clinical data supports this specific combination.
- !Starting two compounds simultaneously makes side effect attribution impossible.
- !Both peptides are WADA prohibited.
- !Not a substitute for medical treatment of injuries.
Frequently Asked Questions
Can I mix BPC-157 and TB-500 in one syringe?
It is recommended to keep them in separate syringes and inject at different sites. Mixing can cause stability issues or aggregation that have not been studied.
Which should I start first?
For localized injuries, BPC-157 alone is more commonly recommended first due to targeted repair properties. For systemic issues, TB-500 may be more appropriate. Starting BPC-157 1-2 weeks first allows assessing individual response.
Is this stack effective for chronic injuries?
Chronic injuries may need longer protocols (8-12 weeks) with moderated expectations. Chronic conditions often have structural changes that peptides may support but not fully reverse.